These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Increased excretion of 5-hydroxy-indole-acetic acid after the administration of 3-indole-acetic acid (heteroauxine). RYSANEK K, VITEK V. Experientia; 1959 Jun 15; 15(6):217-8. PubMed ID: 13672177 [No Abstract] [Full Text] [Related]
24. [Excretion of 5-hydroxyindolacetic acid in glaucoma patients]. SAMAN K, LAHN V, VIRT S. Cesk Oftalmol; 1961 Nov 15; 17():487-94. PubMed ID: 14496566 [No Abstract] [Full Text] [Related]
31. SEROTONIN, 5-hydroxyindoleacetic acid and cancer. Nutr Rev; 1957 May 15; 15(5):156-7. PubMed ID: 13431094 [No Abstract] [Full Text] [Related]
32. [Clinical manifestations and detection of 5-hydroxy-indolacetic acid and 5-hydroxy-tryptamine in metastasizing carcinoid of the small intestine]. HEGGLIN R, LANGEMANN H. Helv Med Acta; 1955 Nov 15; 22(4-5):463-9. PubMed ID: 13285817 [No Abstract] [Full Text] [Related]
36. Metastasizing carcinoid and 5-hydroxytryptamine. JENSEN K. Dan Med Bull; 1957 May 15; 4(3):96-101. PubMed ID: 13437704 [No Abstract] [Full Text] [Related]